Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01031043 · ClinicalTrials.gov registry record · Phase 1
Topical Bethanechol for Improvement of Esophageal Dysmotility
A Phase 1 study, sponsored by Augusta University.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT01031043 is a Phase 1 study that has completed, run by Augusta University. The registered enrollment target is 5 participants.
The verdict
NCT01031043, a Phase 1 study, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this research project is to determine the effect of a drug called bethanechol on swallowing function in patients with Ineffective Esophageal Motility (IEM). This drug is FDA approved for use in treating other conditions, but not for the treatment of IEM. There is currently no approved therapy for the treatment of IEM. This information is important for the possible development of new ways of treating patients with IEM and for the effectiveness of topically applied Bethanechol on patients with IEM.
Interventions
- DRUG Bethanechol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01031043
The ClinicalTrials.gov registry entry for NCT01031043 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bethanechol is the first listed.
NCT01031043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01031043 about?
NCT01031043 is a clinical study titled "Topical Bethanechol for Improvement of Esophageal Dysmotility". The purpose of this research project is to determine the effect of a drug called bethanechol on swallowing function in patients with Ineffective Esophageal Motility (IEM). This drug is FDA approved for use in treating other conditions, but not for the treatment of IEM. There is currently no approved...
What is the current status of trial NCT01031043?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2009-11. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01031043?
The interventions under investigation include: Bethanechol (DRUG).
Who is sponsoring clinical trial NCT01031043?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.